Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
Authors:
- Dvir ShechterDSDvir Shechter
- Michal HarelMHMichal Harel
- Abhishek MukherjeeAMAbhishek Mukherjee
- Leonel M. SagredoLSLeonel M. Sagredo
- David LovenDLDavid Loven
- Elad PrinzEPElad Prinz
- Shimrit AvrahamSAShimrit Avraham
- Veronique Orian-RousseauVeronique Orian-Rousseau
- Tamar GeigerTGTamar Geiger
- Yuval ShakedYSYuval Shaked
- Haguy WolfensonHWHaguy Wolfenson
Open Access
Abstract
Tumor cell heterogeneity is primarily dictated by mutational changes, sometimes leading to clones that undergo a metastatic switch. However, little is known about tumor heterogeneity following chemotherapy perturbation. Here we studied the possible involvement of tumor-derived extracellular vesicles, often referred to as tumor-derived microparticles (TMPs), as mediators of the metastatic switch in the tumor microenvironment by hindering cell adhesion properties. Specifically, we show that highly metastatic or chemotherapy-treated breast cancer cells shed an increased number of TMPs compared to their respective controls. We found that these TMPs substantially reduce cell adhesion and disrupt actin filament structure, therefore increasing their biomechanical force pace, further implicating tumor cell dissemination as part of the metastatic cascade. Our results demonstrate that these pro-metastatic effects are mediated in part by CD44 which is highly expressed in TMPs obtained from highly metastatic cells or cells exposed to chemotherapy when compared to cells with low metastatic potential. Consequently, when we inhibited CD44 expression on TMPs by a pharmacological or a genetic approach, increased tumor cell adhesion and re-organized actin filament structure were observed. We also demonstrated that breast cancer patients treated with paclitaxel chemotherapy exhibited increased CD44-expressing TMPs. Overall, our study provides further insights into the role of TMPs in promoting metastasis, an effect which is augmented when tumor cells are exposed to chemotherapy.Keywords
Funding Information
- Israel Science Foundation (1738/17)
- H2020 European Research Council (771112)
- Rappaport Institute for Greater Boston, Harvard Kennedy School (na)
This publication has 52 references indexed in Scilit:
- Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to CellsPLOS ONE, 2013
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Cells test substrate rigidity by local contractions on submicrometer pillarsProceedings of the National Academy of Sciences, 2012
- Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in MiceCancer Research, 2011
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant EnvironmentJournal of Proteome Research, 2011
- Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in MalignancyClinical Cancer Research, 2009
- CD44 variant isoforms in head and neck squamous cell carcinoma progressionThe Laryngoscope, 2009
- Illuminating the metastatic processNature Reviews Cancer, 2007
- Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTipsNature Protocols, 2007
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001